Lv5
950 积分 2021-08-05 加入
Encorafenib/binimetinib induced severe liver injury in a melanoma patient: Case report and review of literature
1天前
待确认
Encorafenib overdose
1天前
已完结
Demystifying BRAF Mutation Status in Colorectal Liver Metastases
1个月前
已完结
Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study
1个月前
已完结
Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective study
1个月前
已完结
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group
1个月前
已完结
Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapy
3个月前
已完结
Dabrafenib: a new opportunity for the treatment of BRAF V600-positive melanoma
3个月前
已完结
Cutaneous Side Effects of Single Versus Combined BRAF Inhibitors: A Comment to Erfan et al
3个月前
已关闭
Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
4个月前
已完结
皖公网安备34019202002308
